Download Free Medical Myocardial infarction PowerPoint Presentation

Myocardial infarction PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Check out this medical titled "Myocardial infarction” by Taras V. Chendey, MD, PhD.

This medical is about myocardial infarction (MI), commonly known as a heart attack. Myocardial infarction occurs when the blood flow to a part of the heart muscle is blocked, usually by a blood clot. The lack of blood flow and oxygen to the heart muscle can cause damage or death to the affected area.

The most common symptoms of a heart attack include chest pain or discomfort, shortness of breath, sweating, nausea, and lightheadedness. However, not all people who have a heart attack experience these symptoms, and some people may have atypical symptoms such as jaw or back pain, fatigue, or indigestion.

Tags : Myocardial infarction, heart attack, Cardiology, Cardiology

Published on : Jun 01, 2023 | Views : 872 | Downloads : 8

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

Myocardial infarction Taras V. Chendey MD, PhD, Chair of Hospital Therapy http://www.uzhnu.edu.ua/uk/infocentre/3984
Slide 2-

Definition Myocardial infarction is an ischemic necrosis of the myocardium, caused by occlusion of coronary artery and prolonged myocardial ischemia. MI is an extreme consequence of acute coronary syndromes – the spectrum of clinical states caused by instability of coronary artery lumen due to plaque instability and (athero)thrombosis
Slide 3-

Epidemilogy >50 000 cases annually in Ukraine, the number is largely underestimated Mortality is high – up to 15%. Up to 60% of deaths occur before hospital admission >1.5 million cases in the US annually(60 cases per 100 000 people)
Slide 4-

Either one of the following criteria satisfies the diagnosis for an acute, evolving, or recent myocardial infarction: 1. Typical rise and gradual fall (troponin) or more rapid rise and fall (CK-MB) of biochemical markers of myocardial necrosis with at least one of the following: a. Ischemic symptoms b. Development of pathologic Q waves on the electrocardiogram c. Electrocardiographic changes indicative of ischemia (ST segment elevation or depression) d. Coronary artery intervention (e.g., coronary angioplasty). 2. Pathological findings of an acute myocardial infarction
Slide 5-

Most patients who sustain an MI have coronary atherosclerosis. The thrombus formation occurs most often at the site of an atherosclerotic lesion, thus obstructing blood flow to the myocardial tissues. Plaque rupture is believed to be the triggering mechanism for the development of the thrombus in most patients with an MI. When the plaques rupture, a thrombus is formed at the site that can occlude blood flow, thus resulting in an MI. Pathophysiological Principles
Slide 6-

ppt slide no 6 content not found
Slide 7-

Irreversible damage to the myocardium can begin as early as 20 to 40 minutes after interruption of blood flow. The dynamic process of infarction may not be completed, however, for several hours. Necrosis of tissue appears to occur in a sequential fashion. Cellular death occurs first in the subendocardial layer and spreads like a “wavefront” throughout the thickness of the wall of the heart. The shorter the time between coronary occlusion and coronary reperfusion, the greater the amount of myocardial tissue that could be salvaged. Pathophysiological Principles
Slide 8-

Time Is Myocardium and the Wavefront of Necrosis CM Gibson 2002
Slide 9-

The cellular changes associated with an MI can be followed by: 1. the development of infarct extension (new myocardial necrosis), 2. infarct expansion (a disproportionate thinning and dilation of the infarct zone), or 3. Ventricular remodeling (a disproportionate thinning and dilation of the ventricle). MIs most often result in damage to the left ventricle, leading to an alteration in left ventricular function. Infarctions can also occur in the right ventricle or in both ventricles. Pathophysiological Principles
Slide 10-

MI Classifications MI’s can be subcategorized by anatomy and clinical diagnostic information. Anatomic Transmural and Subendocardial Diagnostic ST elevations (STEMI) and non ST elevations (NSTEMI).
Slide 11-

MIs can be located in the anterior, septal, lateral, posterior, or inferior walls of the left ventricle. LOCATION OF THE INFARCTION
Slide 12-

Diagram of the coronary arteries arising from the aorta and encircling the heart. Some of the coronary veins also are shown.
Slide 13-

ppt slide no 13 content not found
Slide 14-

HISTORY patients with MI describe a heaviness, squeezing, choking, or smothering sensation. Patients often describe the sensation as “someone sitting on my chest.” The substernal pain can radiate to the neck, left arm, back, or jaw. Unlike the pain of angina, the pain of an MI is often more prolonged and unrelieved by rest or sublingual nitroglycerin. Associated findings on history include nausea and vomiting, especially for the patient with an inferior wall MI. These gastrointestinal complaints are believed to be related to the severity of the pain and the resulting vagal stimulation. Assessment
Slide 15-

PHYSICAL EXAMINATION patients usually appear restless and in distress. The skin is warm and moist. Breathing may be labored and rapid. Fine crackles, coarse crackles, or rhonchi may be heard when auscultating the lungs. an increased blood pressure related to anxiety or a decreased blood pressure caused by heart failure. The heart rate may vary from bradycardia to tachycardia. On auscultation, the first heart sound may be diminished as a result of decreased contractility. A fourth heart sound is heard in almost all patients with MI, whereas a third heart sound is detected in only about 10% to 20% of patients. Transient systolic murmurs may be heard After about 48 to 72 hours, many patients acquire a pericardial friction rub Patients with right ventricular infarcts may present with jugular vein distension, peripheral edema, and an elevated central venous pressure.
Slide 16-

The Electrocardiogram An ECG can be used to detect patterns of ischemia, injury, and infarction DIAGNOSTIC TESTS
Slide 17-

Infarction. When myocardial injury persists, MI is the result. During the earliest stage of MI, known as the hyperacute phase, the T waves become tall and narrow. This configuration is referred to as hyperacute or peaked T waves. Within a few hours, these hyperacute T waves invert. Next, the ST segments elevate, a pattern that usually lasts from several hours to several days. In addition to the ST segment elevations in the leads of the ECG facing the injured heart, the leads facing away from the injured area may show ST segment depression. This finding is known as reciprocal ST segment changes.
Slide 18-

The last stage in the ECG evolution of an MI is the development of Q waves, the initial downward deflection of the QRS complex. Q waves represent the flow of electrical forces toward the septum. Small, narrow Q waves may be seen in the normal ECG in leads I, II, III, aVR, aVL, V5, and V6. Q waves compatible with an MI are usually 0.04 second (one small box) or more in width or one-fourth to one-third the height of the R wave. Q waves indicative of infarction usually develop within several hours of the onset of the infarction, but in some patients may not appear until 24 to 48 hours after the infarction.
Slide 19-

Within a few days after the MI, the elevated ST segments return to baseline. Persistent elevation of the ST segment may indicate the presence of a ventricular aneurysm. The T waves may remain inverted for several weeks, indicating areas of ischemia near the infarct region. Eventually, the T waves should return to their upright configuration. The Q waves do not disappear and therefore always provide ECG evidence of a previous MI.
Slide 20-

Q waves indicate tissue necrosis and are permanent. A pathologic Q wave is one that is greater than 3 mm in depth or greater than one-third the height of the R wave.
Slide 21-

To attain an accurate view of the right ventricle, right-sided chest leads are recorded by placing the six chest electrodes on the right side of the chest using landmarks analogous to those used on the left side To detect posterior wall abnormalities, three of the precordial electrodes are placed posteriorly over the heart, a view known as V7, V8, and V9. V7 is positioned at the posterior axillary line; V8 at the posterior scapular line; and V9 at the left border of the spine
Slide 22-

Laboratory Tests Creatine Kinase CK-MB appears in the serum in 6 to 12 hours, peaks between 12 and 28 hours, and returns to normal levels in about 72 to 96 hours. Serial samplings are performed every 4 to 6 hours for the first 24 to 48 hours after the onset of symptoms Myoglobin: The myoglobin level can elevate within 1 to 2 hours of acute MI and peaks within 3 to 15 hours. Troponin. (troponin T and troponin I): Troponin I levels rise in about 3 hours, peak at 14 to 18 hours, and remain elevated for 5 to 7 days. Troponin T levels rise in 3 to 5 hours and remain elevated for 10 to 14 days
Slide 23-

Release of cardiac markers after acute myocardial infarction (AMI).
Slide 24-

EARLY MANAGEMENT The patient’s history and 12-lead ECG are the primary methods used to determine initially the diagnosis of MI. The ECG is examined for the presence of ST segment elevations of 1 mV or greater in contiguous leads. 1. Administer aspirin, 160 to 325 mg chewed. 2. After recording the initial 12-lead ECG, place the patient on a cardiac monitor and obtain serial ECGs. 3. Give oxygen by nasal cannula. Management
Slide 25-

4. Administer sublingual nitroglycerin (unless the systolic blood pressure is less than 90 mm Hg or the heart rate is less than 50 or greater than 100 beats/minute). 5. Provide adequate analgesia with morphine sulfate. Provide adequate analgesia with morphine sulfate.
Slide 26-

PCI is the most effective alternative to reestablish blood flow to ischemic myocardium. Primary PCI is an invasive procedure in which the infarct-related coronary artery is dilated during the acute phase of an MI without prior administration of thrombolytic agents. Primary PCI may be an excellent reperfusion alternative for patients presenting within 2 hours of symptoms onset Door-to-baloon time should be attained in 60 min interval Clopidogrel loading dose 300-600 mg or ticagrelor 180 mg is given prior to the PCI. Dual antiplatelet therapy with aspirin and clopidogrel or ticagrelor is given afterwadrs for 12 months. Primary coronary intervention (PCI): angioplasty and stenting
Slide 27-

Thrombolytic drugs lyse coronary thrombi by converting plasminogen to plasmin. Thrombolytic therapy provides maximal benefit if given within the first 3 hours after the onset of symptoms. Significant benefit still occurs if therapy is given up to 12 hours after onset of symptoms. Contraindications ■ Previous hemorrhagic stroke at any time; other stokes or cerebrovascular events within 1 year ■ Known intracranial neoplasm ■ Active internal bleeding (does not include menses) ■ Suspected aortic dissection Thrombolytic Therapy
Slide 28-

Cautions/Relative Contraindications ■ Severe uncontrolled hypertension on presentation (blood pressure >180/110 mm Hg) ■ History of prior cerebrovascular accident or known intracerebral disease not covered in contraindications ■ Current use of anticoagulants in therapeutic doses (international normalized ratio [INR] ≥2:3); known bleeding diathesis ■ Recent trauma (within 2–4 weeks), including head trauma or traumatic or prolonged (>10 minutes) cardiopulmonary resuscitation (CPR) or major surgery (<3 weeks) Thrombolytic Therapy
Slide 29-

■ Noncompressible vascular punctures ■ Recent (within 2–4 weeks) internal bleeding ■ For streptokinase/anistreplase: prior exposure (especially within 5 days to 2 years) or prior allergic reaction ■ Pregnancy ■ Active peptic ulcer
Slide 30-

Prophylactic antidysrhythmics during the first 24 hours of hospitalization are not recommended. IV nitroglycerin is continued for 24 to 48 hours. Daily aspirin is continued on an indefinite basis. Clopidogrel or other P2Y12 antagonist is continued for 1 year. IV beta blocker therapy should be administered within the initial hours of the evolving infarction, followed by oral therapy provided there are no contraindications. They reduce oxygen demand by decreasing the heart rate and contractility. They also increase coronary artery filling by prolonging diastole. INTENSIVE AND INTERMEDIATECARE MANAGEMENT
Slide 31-

Angiotensin-converting enzyme (ACE) inhibitors are administered to patients with anterior wall MI and to patients who have an MI with heart failure in the absence of significant hypotension. ACE inhibitors help prevent ventricular remodeling (dilation) and preserve ejection fraction. Heparin is given to patients undergoing percutaneous or surgical revascularization and for those receiving thrombolytic therapy with alteplase. Low–molecular-weight heparin should be used for patients with non–Q-wave MI INTENSIVE AND INTERMEDIATECARE MANAGEMENT
Slide 32-

Hemodynamic Monitoring Use of a pulmonary artery catheter for hemodynamic monitoring is indicated in the patient with MI who has severe or progressive congestive heart failure or pulmonary edema, cardiogenic shock, progressive hypotension, or suspected mechanical complications. Additional Diagnostic Tests: Radionuclide Imaging Echocardiogram Stress Test Coronary Angiography
Slide 33-

Complications Vascular Complications Recurrent ischemia Recurrent infarction Mechanical Complications Left ventricular free wall rupture Ventricular septal rupture Papillary muscle rupture with acute mitral regurgitation Myocardial Complications Diastolic dysfunction Systolic dysfunction Congestive heart failure Hypotension/cardiogenic shock Right ventricular infarction Ventricular cavity dilation Aneurysm formation (true, false)
Slide 34-

Complications Pericardial Complications Pericarditis Dressler’s syndrome Pericardial effusion Thromboembolic Complications Mural thrombosis Systemic thromboembolism Deep venous thrombosis Pulmonary embolism Electrical Complications Ventricular tachycardia Ventricular fibrillation Supraventricular tachydysrhythmias Bradydysrhythmias Atrioventricular block (first, second, or third degree)